Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) EBT (2018 - 2025)

Select Medical Holdings (SEM) has disclosed EBT for 8 consecutive years, with $50.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 437.71% to $50.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $272.7 million, a 56.06% increase, with the full-year FY2025 number at $272.7 million, up 56.06% from a year prior.
  • EBT was $50.5 million for Q4 2025 at Select Medical Holdings, down from $55.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $261.9 million in Q2 2021 to a low of -$179.0 million in Q4 2022.
  • A 5-year average of $62.6 million and a median of $55.9 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 410.42% in 2022, then skyrocketed 558.83% in 2024.
  • Select Medical Holdings' EBT stood at $57.7 million in 2021, then tumbled by 410.42% to -$179.0 million in 2022, then skyrocketed by 119.48% to $34.9 million in 2023, then crashed by 142.85% to -$14.9 million in 2024, then surged by 437.71% to $50.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's EBT are $50.5 million (Q4 2025), $55.9 million (Q3 2025), and $70.2 million (Q2 2025).